Leica Biosystems new dual detection kit enables clinicians to get more information out of their tissue samples. June 9, 2023, NEWCASTLE, UK - Leica Biosystems is pleased to announce the launch of BOND ChromoPlex II Dual Detection, a...

Leica Biosystems: How the Leeds Guide and its Business Cases Can Help Transform Your Lab Developing an effective business case for deploying DP can be one of the most daunting tasks a department can face. Your priority should be to define...

Leica Biosystems: The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug...

Leica Biosystems to adopt Paige's image management and AI system for sale with Leica Biosystems Aperio digital pathology slide scanners NEW YORK and VISTA, Calif. – March 13, 2023 – Paige, a global leader in end-to-end digital...

Leica Webinar Announcement: Combining RNAscope™ Technology with Protein Detection: A Multi Omics approach using RNA-Protein Integrated Co-Detection Workflow (ICW) Date: February 23, 2023 Time: 8:00 a.m. (PST), 11:00 a.m. (EST), 5:00...

The history of Leica Biosystems is a history of science and technology innovation. For 150+ years, we’ve tackled pathology challenges head-on – from company founder Rudolf Jung building the first microtome to today’s world-leading...